Kelly Financial Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-529
Closed -$206K 119
2025
Q2
$206K Sell
529
-28
-5% -$11.3K 0.06% 113
2025
Q1
$242K Hold
557
0.08% 96
2024
Q4
$205K Buy
557
+23
+4% +$9.63K 0.07% 112
2024
Q3
$278K Buy
534
+13
+2% +$6.95K 0.1% 89
2024
Q2
$282K Sell
521
-55
-10% -$29.1K 0.1% 87
2024
Q1
$299K Buy
576
+563
+4,331% +$280K 0.11% 88
2023
Q4
$6.13K Buy
+13
New +$6.01K ﹤0.01% 452

Other funds holding ELV

Kelly Financial Services's ELV Position: Q3 2025 in Review

Kelly Financial Services sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 529 shares — an estimated $206K sold.

Kelly Financial Services first reported a position in ELV in Q4 2023 and held it in 7 quarters. The position peaked at $299K in Q1 2024. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Kelly Financial Services reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Kelly Financial Services sold 529 Elevance Health shares in Q3 2025, an estimated $206K.
  • Kelly Financial Services first reported a position in Elevance Health in Q4 2023 and held it in 7 quarters.
  • Kelly Financial Services's Elevance Health position peaked at $299K in Q1 2024.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Kelly Financial Services's 13F filing for Q3 2025, filed 15 Oct 2025.